Search Results
Dec 03, 2025, 09:05 ET FMI Reports Strong 11.7% CAGR Growth Outlook for the GLP-1 Receptor Agonist Market Through 2035
demand for GLP-1 therapies.United KingdomWith a mature healthcare ecosystem, the UK continues to expand access through NHS coverage and proactive preventive-care programs.Competitive Landscape: Manufacturers Strengthen Pipelines Amid Global DemandLeading
More news about: Future Market Insights, Inc.
Dec 03, 2025, 09:00 ET Iris® Powered by Generali Recaps 2025 Product Enhancements and Major Industry Recognition
also extended its medical monitoring suite with identifiers including Medical Record Number (MRN), Medicare Beneficiary Identifier (MBI), and the UK NHS number. Social Media Monitoring capabilities were also broadened to support four additional EU languages (Spanish, French, German, and Italian), enabling
More news about: Iris Powered by Generali
Dec 03, 2025, 07:34 ET Virax Biolabs' CEO James Foster Outlines Clinical Progress and 2026 Priorities in Latest Annual Letter to Shareholders
Lyme disease ("PTLD"), and ME/CFS. This multi-site study, involving five clinical centres and run in collaboration with the National Health Service ("NHS"), is designed to generate the clinical data required to support planned regulatory submissions and ultimately to help inform patient care over time.
More news about: Virax BioLabs Group Limited
Dec 02, 2025, 18:30 ET Brainomix Announces New Study Published in Lancet Digital Health Demonstrating Impact of Brainomix 360 Stroke to Increase Endovascular Thrombectomy Rates
this unique collaboration with clinical teams across NHS England and the Health Innovation Network, we have demonstrated the generalisable impact that stroke AI technology can have for improving patient care."Dr David Hargroves, NHS National Clinical Director for Stroke and co-author of
More news about: Brainomix
Dec 02, 2025, 18:16 ET Accord Healthcare annonce le lancement de son deuxième biosimilaire du denosumab dans le domaine de la santé osseuse
Royaume-Uni et en Europe. En mettant l'accent sur la qualité, l'accessibilité et la durabilité, Accord travaille avec les professionnels de la santé et le NHS afin d'améliorer les résultats pour les patients et d'apporter une valeur ajoutée dans des domaines thérapeutiques tels que l'oncologie, la santé osseuse
More news about: Accord Healthcare
Dec 02, 2025, 18:11 ET Accord Healthcare kündigt Einführung von Denosumab∇ an - zweites Biosimilar im Bereich Knochengesundheit
Königreich und Europa. Accord konzentriert sich auf Qualität, Zugänglichkeit sowie Nachhaltigkeit und arbeitet mit Fachleuten des Gesundheitswesens und dem NHS zusammen, um die Ergebnisse für Patienten zu verbessern sowie einen Mehrwert in verschiedenen Therapiebereichen wie Onkologie, Knochengesundheit und
More news about: Accord Healthcare
Dec 02, 2025, 18:00 ET Accord Healthcare anuncia el lanzamiento de Denosumab∇, el segundo biosimilar para la salud ósea
el Reino Unido y Europa. Gracias a su enfoque en la calidad, la accesibilidad y la sostenibilidad, Accord colabora con profesionales sanitarios y el NHS para mejorar los resultados de los pacientes y aportar valor en áreas terapéuticas como la oncología, la salud ósea y las enfermedades autoinmunes.Referencias:1.Información
More news about: Accord Healthcare
Dec 02, 2025, 17:53 ET Accord Healthcare anuncia o lançamento do Denosumabe∇ - Segundo Biossimilar em Saúde Óssea
cresce no Reino Unido e na Europa. Por meio de seu foco em qualidade, acessibilidade e sustentabilidade, a Accord trabalha com profissionais de saúde e o NHS para melhorar os resultados dos pacientes e oferecer valor em áreas terapêuticas, incluindo oncologia, saúde óssea e doenças autoimunes.Referências:
More news about: Accord Healthcare
Dec 02, 2025, 17:50 ET Accord Healthcare anuncia el lanzamiento de Denosumab∇, segundo biosimilar en salud ósea
crecimiento en el Reino Unido y Europa. Mediante su enfoque en calidad, accesibilidad y sostenibilidad, Accord trabaja con profesionales de la salud y el NHS para mejorar los resultados de los pacientes y ofrecer valor en áreas terapéuticas como la oncología, la salud ósea y las enfermedades autoinmunes.Referencias:
More news about: Accord Healthcare
Dec 02, 2025, 02:00 ET Accord Healthcare Announces Launch of Denosumab∇ - Second Biosimilar in Bone Health
companies in the UK and Europe. Through its focus on quality, accessibility, and sustainability, Accord works with healthcare professionals and the NHS to improve patient outcomes and deliver value across therapeutic areas including oncology, bone health, and autoimmune disease.References:
More news about: Accord Healthcare
Dec 02, 2025, 02:00 ET Accord Healthcare Announces Launch of Denosumab∇ - Second Biosimilar in Bone Health
companies in the UK and Europe. Through its focus on quality, accessibility, and sustainability, Accord works with healthcare professionals and the NHS to improve patient outcomes and deliver value across therapeutic areas including oncology, bone health, and autoimmune disease.References:
More news about: Accord Healthcare
Nov 28, 2025, 16:30 ET NEUBERGER BERMAN HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTION
YORK, Nov. 28, 2025 /PRNewswire/ -- Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on December
More news about: Neuberger Berman
Nov 26, 2025, 11:49 ET Metered Dose Inhalers Market to Reach $18.4 billion, Globally, by 2034 at 6.2% CAGR: Allied Market Research
Countries like the UK, Germany, and the Netherlands are actively transitioning to low-emission inhalers under NHS and EU Green Deal mandates. In the UK alone, the National Health Service (NHS) has set a target to reduce the carbon footprint of inhalers by 50% by 2028. This regulatory push is prompting
More news about: Allied Market Research
Nov 26, 2025, 03:00 ET Queen Square launches podcast to support Parkinson's and Essential Tremor patients
here.Queen Square Imaging Centre is a world-leading neuroimaging facility and specialist diagnostic imaging centre, serving NHS and private patients. As part of Queen Square Enterprises, a not-for-profit organisation, the centre provides advanced neuroimaging services and treatments,
More news about: Queen Square Imaging
Nov 26, 2025, 03:00 ET Queen Square launches podcast to support Parkinson's and Essential Tremor patients
here.Queen Square Imaging Centre is a world-leading neuroimaging facility and specialist diagnostic imaging centre, serving NHS and private patients. As part of Queen Square Enterprises, a not-for-profit organisation, the centre provides advanced neuroimaging services and treatments,
More news about: Queen Square Imaging
Nov 26, 2025, 03:00 ET Queen Square lance un podcast pour soutenir les patients atteints de la maladie de Parkinson et de tremblements essentiels
Queen Square Imaging Centre est un centre de neuro-imagerie de pointe et un centre d'imagerie diagnostique spécialisé, au service des patients du NHS et du secteur privé. Faisant partie de Queen Square Enterprises, une organisation à but non lucratif, le centre fournit des services et des traitements
More news about: Queen Square Imaging
Nov 21, 2025, 08:15 ET Global AI Evaluation Service Launched Across UK, US and Europe
for Children, Leeds Teaching Hospitals NHS Trust, NHS Greater Glasgow and Clyde, Tanner Health and other reputable health systems within the Newton's Tree network.Chris Herbert, Director of Operations, Research and Innovation at Leeds Teaching Hospitals NHS Trust, United Kingdom, highlighted the
More news about: Newton’s Tree
Nov 20, 2025, 08:30 ET BioWave® Announces New Clinical Data Demonstrating Impactful Non-Invasive Pain Relief for War-Related Injuries and Home-Based Treatments
1 Pain Management Centre, Imperial College Healthcare NHS Trust, London, United Kingdom 2 Member
More news about: BioWave
Nov 18, 2025, 04:00 ET Surface contamination linked to 1.27 million AMR deaths - experts warn of hidden threat
Hydrachem's expertise extends across 60 countries, supplying disinfection solutions trusted by hospitals, humanitarian organisations and the NHS. The company's BIOSPOT surface disinfection
More news about: Hydrachem
Nov 18, 2025, 04:00 ET Over 460k instances of stolen employee credentials discovered across FTSE 100, Socura report reveals
Socura, a UK-based cyber security services provider that protects many of the nation's biggest NHS trusts, councils, and private companies, has released its report,
More news about: Socura
Nov 14, 2025, 08:24 ET LODD 完成 Hili 首次飛行 -- 阿聯酋首架於阿布扎比設計、製造及測試的混合動力重型貨運無人機
Skyports Drone Services（英國）：在首飛儀式上，LODD 亦與全球公認的無人機營運領導者 Skyports Drone Services 簽署協議。Skyports 目前為 Royal Mail、NHS 及 Equinor 和 RWE 等離岸能源巨擘營運無人機送貨服務。Skyports 認為 Hili 具備巨大潛力，有助擴展其重型、遠程貨運無人機的運載能力。
More news about: Abu Dhabi Autonomous Week
Nov 14, 2025, 07:54 ET LODD、アブダビで設計・製造・試験を実施したUAE初のハイブリッド大型貨物無人航空機「Hili」の初飛行を完了
Skyports Drone Services（英国）：初飛行セレモニーの場で、LODDはドローン運航分野で信頼される世界的リーダー、Skyports Drone Servicesとも協定を締結しました。Royal Mail、NHS、EquinorやRWEなどの洋上エネルギー企業向けにドローン配送を運営するSkyportsは、重量物・長距離貨物ドローンの能力拡大について大きな可能性をHiliに見出しています。 ST Engineering（シンガポール）：初飛行セレモニーにおいて、LODDは世界最大級の航空宇宙企業の1つであるST Engineeringの商用航空宇宙事業部門と正式な協定を締結し、Hiliをアジア太平洋地域の主要市場へ展開していくことになりました。これは両社間の包括的戦略的提携の一環です。
More news about: Abu Dhabi Autonomous Week
Nov 14, 2025, 07:08 ET LODD absolviert ersten Flug von Hili - dem ersten hybriden Schwerlast-UAV der Vereinigten Arabischen Emirate, das in Abu Dhabi entwickelt, gebaut und getestet wurde
Skyports Drone Services, einem weltweit führenden und vertrauenswürdigen Anbieter von Drohnenbetrieb. Skyports, das Drohnenlieferungen für Royal Mail, den NHS und führende Offshore-Energieunternehmen wie Equinor und RWE durchführt, sieht in Hili ein großes Potenzial für den Ausbau seiner Fähigkeiten im Bereich
More news about: Abu Dhabi Autonomous Week
Nov 14, 2025, 07:05 ET LODD conclui o primeiro voo do Hili - o primeiro UAV híbrido de carga pesada dos Emirados Árabes Unidos, projetado, construído e testado em Abu Dhabi
acordo com a Skyports Drone Services, uma líder global confiável em operações com drones. Realizando operações de entrega com drones para a Royal Mail, o NHS e líderes de energia offshore como Equinor e RWE, a Skyports vê um grande potencial no Hili para expandir suas capacidades de drone de carga de elevação
More news about: Abu Dhabi Autonomous Week
Nov 14, 2025, 07:01 ET LODD completa el primer vuelo del Hili, el primer UAV híbrido para carga pesada de los Emiratos Árabes Unidos, diseñado, construido y probado en Abu Dabi
mundial de confianza en operaciones con drones. Skyports, que realiza operaciones de entrega con drones para Royal Mail, el Servicio Nacional de Salud (NHS) y líderes del sector energético offshore como Equinor y RWE, ve un gran potencial en Hili para ampliar sus capacidades en materia de drones de carga
More news about: Abu Dhabi Autonomous Week